Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (321-330 of 651) with videos related to

Pageof 66
Sort By:
Cancer|December 15, 1989
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tractJ T Barrett, B Orofiamma, J D Khandekar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer modelsYunguang Sun, Luigi Moretti, Nicholas J Giacalone, et al.
Neoplasia (New York, N.Y.)|August 1, 2022
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapyShuxiao Guan, Shankar Suman, Joseph M Amann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivoJ E Ohm, M R Shurin, C Esche, et al.
Cancer Research|August 1, 1992
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutationS F Winter, J D Minna, B E Johnson, et al.
Investigational New Drugs|November 1, 1992
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three daysH Bailey, P Kohler, R Tuttle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigatorsK M Taylor, M L Feldstein, R T Skeel, et al.
Cancer Chemotherapy Reports|April 1, 1971
Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orallyC L Vogel, V T DeVita, C Denham, et al.
Cancer|July 15, 1985
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerG Falkson, R S Gelman, D C Tormey, et al.
Placenta|September 1, 1986
Glucocorticoid and progesterone receptors in yolk sac placentaJ P Carbone, R C Baldridge, A B Magen, et al.
Pageof 66

Showing results (321-330 of 651) with videos related to

Sort By:
Pageof 66
Cancer|December 15, 1989
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tractJ T Barrett, B Orofiamma, J D Khandekar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer modelsYunguang Sun, Luigi Moretti, Nicholas J Giacalone, et al.
Neoplasia (New York, N.Y.)|August 1, 2022
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapyShuxiao Guan, Shankar Suman, Joseph M Amann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivoJ E Ohm, M R Shurin, C Esche, et al.
Cancer Research|August 1, 1992
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutationS F Winter, J D Minna, B E Johnson, et al.
Investigational New Drugs|November 1, 1992
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three daysH Bailey, P Kohler, R Tuttle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigatorsK M Taylor, M L Feldstein, R T Skeel, et al.
Cancer Chemotherapy Reports|April 1, 1971
Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orallyC L Vogel, V T DeVita, C Denham, et al.
Cancer|July 15, 1985
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerG Falkson, R S Gelman, D C Tormey, et al.
Placenta|September 1, 1986
Glucocorticoid and progesterone receptors in yolk sac placentaJ P Carbone, R C Baldridge, A B Magen, et al.
Pageof 66